Resistance-Associated Mutations in Chronic Lymphocytic Leukemia Patients Treated With Novel Agents https://t.co/OmOQaTO6zR Important
174 followers
174 followers
RT @BStuetz: very important to consider in treatment duration and use of different novel agents https://t.co/iVgUgopp8b
174 followers
very important to consider in treatment duration and use of different novel agents https://t.co/iVgUgopp8b
6,531 followers
New research: Resistance-Associated Mutations in Chronic Lymphocytic Leukemia Patients Treated With Novel Agents: Inhibitors of B-cell receptor signaling, ibrutinib and idelalisib, and BCL-2 antagonist, venetoclax, have become the mainstay of… https://t.co